A total of 11% of RSV patients experienced a cardiac event, abnormal heart rhythm, heart failure, or ischemic heart disease.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
The Centers for Disease Control and Prevention (CDC), in its weekly FluView report today, noted that cases are rising across the United States, and two states, Louisiana and South Carolina, are seeing moderate activity.
The Saudi Arabian Ministry of Health (MOH) reported two new cases of MERS-CoV infection yesterday and today and the death of a previously reported patient.
A 49-year-old Saudi man from Unayzah is in critical condition after presenting with symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus), the MOH reported yesterday. The man had indirect contact with camels, a known risk factor for MERS.
A US Centers for Disease Control and Prevention–led study published yesterday in Clinical Infectious Diseases reveals that antiviral drugs are prescribed to only 15% of outpatients who have acute respiratory infections (ARIs) and a high risk for influenza.
The data underscore a need to increase appropriate prescribing, the authors said.
A phase 2 study of intravenous (IV) zanamivir in children hospitalized with severe influenza found that treatment was safe, reduced viral load, and was associated with clinical improvement, researchers reported yesterday in an early online edition of Pediatrics.
The World Health Organization (WHO) announced today that tests have ruled out plague in several patients in Seychelles under monitoring and treatment for probable or suspected pneumonic infections. The set of samples included one from a 34-year-old man who had returned from Madagascar and who was previously identified by the Seychelles health ministry as a probable imported case, based on a weakly positive result on a rapid test.
Influenza is finally on the decline in Australia, according to yesterday's global flu update from the World Health Organization (WHO). Influenza A, H3N2, remained the dominant circulating strain, followed by influenza B.
Weekly flu season reports resumed today in the United States and Europe, with low flu activity reported in both parts of the world, according to updates today from the US Centers for Disease Control and Prevention (CDC) and a collaboration between the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization (WHO) Regional Office for Europe.
Italy's chikungunya outbreak has expanded to a second region, and the total number of suspected or confirmed cases has climbed to 298 as of Oct 4, a rise of 115 cases from World Health Organization's update at the end of September.
The observational study found 46% protection but is smaller than an earlier one that showed no protection.
California researchers have developed a rapid test to detect antibiotic susceptibility in urinary tract infections (UTIs) in less than 30 minutes, which could allow patients to be diagnosed and prescribed effective antibiotics during just one healthcare visit, according to a study today in Science Translational Medicine.
